Supplementary Table 3 from Rationale and Preclinical Efficacy of a Novel Anti-EMP2 Antibody for the Treatment of Invasive Breast Cancer

Autor:	Madhuri Wadehra, Lee Goodglick, Manuel L. Penichet, Robert A. Soslow, Yahya Elshimali, Jonathan Braun, Lynn K. Gordon, Najib Aziz, Tracy R. Daniels-Wells, Negin Ashki, Yu Qin, Meagan Kiyohara, Gustavo F. Helguera, Erin L. Maresh, Maoyong Fu
Rok vydání:	2023
DOI:	10.1158/1535-7163.22499967.v1
Popis:	PDF - 51K, Supplementary Table 3. Expression levels of EMP2 in triple negative breast cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128211a4146dfed1a638276d82c0ff2a https://doi.org/10.1158/1535-7163.22499967.v1 Zobrazit plný text záznamu